Prosecution Insights
Last updated: April 19, 2026

Setolas Holdings Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
2
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18685051 MAGNESIUM OXIDE TABLETS BASQUILL, SEAN M 1614 Non-Final OA Feb 20, 2024
18293272 MAGNESIUM OXIDE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATING PEDIATRIC CHRONIC FUNCTIONAL CONSTIPATION JUSTICE, GINA CHIEUN YU 1617 Non-Final OA Jan 29, 2024
18289089 COMPOSITE METAL OXIDE KURTZ, BENJAMIN M 1779 Non-Final OA Oct 31, 2023
18284991 CYTOKINE PRODUCTION SUPPRESSING COMPOSITION CONTAINING D-ALLOSE AS ACTIVE COMPONENT, AND METHOD OF TREATING OR PREVENTING DISEASE ASSOCIATED WITH CYTOKINE OVERPRODUCTION USING SAME BRANDSEN, BENJAMIN MICHAEL 1693 Non-Final OA Sep 29, 2023
18279373 ZINC-CONTAINING HYDROTALCITE DAVIS, SHENG HAN 1732 Non-Final OA Aug 29, 2023
18023988 SURFACE-TREATED HYDROTALCITE, SUSPENSION OF SAME, AND FUNCTIONAL MOLECULE DELIVERY SYSTEM USING SAME DAVIS, SHENG HAN 1732 Final Rejection Feb 28, 2023
17913587 COMPOSITION WHICH IS FOR TREATING OR PREVENTING RENAL CELL CANCER AND CONTAINS D-ALLOSE AS ACTIVE INGREDIENT, AND METHOD FOR TREATING OR PREVENTING CANCER USING SAME HIBSHMAN, SARAH GRACE 1693 Final Rejection Sep 22, 2022

Managing Setolas Holdings Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month